|
|
| rezafungin topical (CD101 topical) / Cidara Therap (0 Trials) |
|
| Rezart E (alfa beta arteether) / Shreya Life Sci (0 Trials) |
|
| Rezart S (artesunate) / Shreya Life Sci (0 Trials) |
|
| rezatapopt (PC14586) / PMV Pharma (0 Trials) |
|
| rezatomidine (AGN 203818) / Acadia Pharma, AbbVie (0 Trials) |
|
| Rezdiffra (resmetirom) / Madrigal Pharma (4 Trials) |
|
| rezetamig (JNJ-8780) / J&J (0 Trials) |
|
| Rezira (hydrocodone bitartrate/pseudoephedrine) / Currax (0 Trials) |
|
| Rezlidhia (olutasidenib) / Rigel (2 Trials) |
|
| Rezonic (casopitant) / GSK (0 Trials) |
|
| rezpegaldesleukin (NKTR-358) / Nektar Therap (0 Trials) |
|
| Rezurock (belumosudil) / Romeck Pharma, Sanofi (11 Trials) |
|
| Rezzayo (rezafungin for injection) / Cidara Therap, Mundipharma, Melinta Therap (3 Trials) |
|
| RF-A089 / Humanwell Healthcare (0 Trials) |
|
| rF1V vaccine with CpG 1018 / Dynavax, US Department of Defense (0 Trials) |
|
| RFB4-N97A / Abiogen (0 Trials) |
|
| RFT-001 / RAFT Pharma (0 Trials) |
|
| RG 7185 / Roche (0 Trials) |
|
| RG 7258 / Roche (0 Trials) |
|
| RG-101 / Regulus Therapeutics (1 Trials) |
|
| RG-125 / AstraZeneca, Regulus Therapeutics (2 Trials) |
|
| RG-1970 / Hangzhou Rongu Biotech (0 Trials) |
|
| RG-NAH005 / Regen BioPharma (0 Trials) |
|
| RG2833 / BioMarin, Johns Hopkins University (0 Trials) |
|
| RG4733 / Roche (0 Trials) |
|
| RG4929 / Roche (0 Trials) |
|
| RG6004 / Roche (0 Trials) |
|
| RG6007 / Roche (0 Trials) |
|
| RG6035 / Roche (0 Trials) |
|
| RG6049 / Roche (0 Trials) |
|
| RG6084 / Roche (0 Trials) |
|
| RG6115 / Roche (0 Trials) |
|
| RG6123 / Roche (0 Trials) |
|
| RG6125 / Roche (0 Trials) |
|
| RG6129 / Roche (0 Trials) |
|
| RG6146 / Roche (0 Trials) |
|
| RG6156 / Roche (0 Trials) |
|
| RG6173 / Roche (0 Trials) |
|
| RG6179 / Roche (0 Trials) |
|
| RG6182 / Roche (0 Trials) |
|
| RG6189 / Roche (0 Trials) |
|
| RG6217 / Roche (0 Trials) |
|
| RG6232 / Roche (0 Trials) |
|
| RG6237 / Roche (0 Trials) |
|
| RG6286 / Roche (0 Trials) |
|
| RG6287 / Roche (0 Trials) |
|
| RG6289 / Roche (0 Trials) |
|
| RG6312 / Roche (0 Trials) |
|
| RG6314 / Roche (0 Trials) |
|
| RG6315 / Roche (0 Trials) |
|
| RG6319 / Roche (0 Trials) |
|
| RG6333 / Roche (0 Trials) |
|
| RG6338 / Roche (0 Trials) |
|
| RG6341 / Roche (0 Trials) |
|
| RG6344 / Roche (0 Trials) |
|
| RG6358 / Roche (0 Trials) |
|
| RG6359 / Roche (0 Trials) |
|
| RG6392 / Roche (0 Trials) |
|
| RG6411 / Roche (0 Trials) |
|
| RG6421 / Roche (0 Trials) |
|
| RG6440 / Roche (0 Trials) |
|
| RG6457 / Roche, Bayer (0 Trials) |
|
| RG6512 / Roche (0 Trials) |
|
| RG6524 / Roche (0 Trials) |
|
| RG6538 / Roche (0 Trials) |
|
| RG6540 / Roche (0 Trials) |
|
| RG6596 / Roche (0 Trials) |
|
| RG6614 / Roche (0 Trials) |
|
| RG6631 / Roche (4 Trials) |
|
| RG6640 / Roche (0 Trials) |
|
| RG6641 / Roche (0 Trials) |
|
| RG70099 / Curadev, Roche (0 Trials) |
|
| RG7089 / Roche (0 Trials) |
|
| RG7112 / Roche (0 Trials) |
|
| RG7129 / Roche (1 Trials) |
|
| RG7212 / Roche (0 Trials) |
|
| RG7234 / Roche (0 Trials) |
|
| RG7356 / Roche (0 Trials) |
|
| RG7386 / Roche (1 Trials) |
|
| RG7410 / Roche (0 Trials) |
|
| RG7444 / Roche (0 Trials) |
|
| RG7594 / Roche (0 Trials) |
|
| RG7598 / Roche (0 Trials) |
|
| RG7600 / Roche (0 Trials) |
|
| RG7602 / Roche (0 Trials) |
|
| RG7637 / Roche (0 Trials) |
|
| RG7652 / Roche (1 Trials) |
|
| RG7667 / Roche (0 Trials) |
|
| RG7697 / Roche (0 Trials) |
|
| RG7741 / Roche, Pfizer (0 Trials) |
|
| RG7775 / Roche (0 Trials) |
|
| RG7800 / Roche (0 Trials) |
|
| RG7827 / Roche (0 Trials) |
|
| RG7835 / Roche (0 Trials) |
|
| RG7863 / Roche (0 Trials) |
|
| RG7882 / Roche (0 Trials) |
|
| RG7893 / Roche, Xenon (0 Trials) |
|
| RG7907 / Roche (0 Trials) |
|
| RG7921 / Roche (0 Trials) |
|
| RG7945 / Roche (0 Trials) |
|
| RGB 03 (rituximab biosimilar) / Stada, Gedeon Richter (0 Trials) |
|
| RGB-14-P (denosumab biosimilar) / Gedeon Richter (0 Trials) |
|
| RGB-286638 / Agennix (0 Trials) |
|
| RGC 1503 / ABVC BioPharma, Rgene Corp (0 Trials) |
|
| RGC-1501 / ABVC BioPharma, Rgene Corp (0 Trials) |
|
| RGC-1502 / ABVC BioPharma, Rgene Corp (0 Trials) |
|
| RGFP966 / BioMarin (0 Trials) |
|
| RGH 363 / Gedeon Richter (0 Trials) |
|
| RGI-1001 / Regimmune (0 Trials) |
|
| RGI-3100 / Regimmune (0 Trials) |
|
| RGI-5000 / Regimmune (0 Trials) |
|
| RGLS4326 / Regulus Therapeutics, Bio-Techne (0 Trials) |
|
| RGLS8429 / Regulus Therapeutics (0 Trials) |
|
| RGN3067 / Reglagene (0 Trials) |
|
| RGRN-305 / Regranion, MC2 Therap (0 Trials) |
|
| RGS 2064 / Regenesance (0 Trials) |
|
| RGT-075 / Regor (0 Trials) |
|
| RGT-419B / Roche (0 Trials) |
|
| RGT-587 / Roche (0 Trials) |
|
| RGV004 / Hangzhou Rongu Biotech (0 Trials) |
|
| RGX-019 / Inspirna (0 Trials) |
|
| RGX-111 / REGENXBIO (1 Trials) |
|
| RGX-121 / REGENXBIO (3 Trials) |
|
| RGX-181 / REGENXBIO (0 Trials) |
|
| RGX-202 / REGENXBIO (0 Trials) |
|
| RGX-501 / REGENXBIO (1 Trials) |
|
| rH & Mix Insulin biosimilar / ACIC (0 Trials) |
|
| rH insulin biosimilar / Harvest Moon (0 Trials) |
|
| rH-GCSF (filgrastim biosimilar) / Biogenomics (0 Trials) |
|
| rh-superoxide dismutase (APN201) / Apeiron Biologics (0 Trials) |
|
| RH109 / Jiangsu Rec-Biotech (0 Trials) |
|
| RH5.1/Matrix-M / University of Oxford (0 Trials) |
|
| RH5.2 VLP in Matrix-MTM / University of Oxford (0 Trials) |
|
| rhAAT / CEVEC (0 Trials) |
|
| RHB-106 / RedHill (0 Trials) |
|
| RHCDS-13b / German Center for Infection Research (0 Trials) |
|
| RHE 70202 / XBiotech (0 Trials) |
|
| RheDQuin (rhesus D antibodies) / Sanquin (0 Trials) |
|
| rhErbB3-f / Zensun (0 Trials) |
|
| Rheumastop plaster (diclofenac diethyl-ammonium) / Samyang Group (0 Trials) |
|
| rheumatoid arthritis gene therapies / Biogen (0 Trials) |
|
| rheumatoid arthritis vaccine (CEL 2000) / CEL-SCI (0 Trials) |
|
| rheumatoid arthritis vaccine (CEL-4000) / CEL-SCI (0 Trials) |
|
| rhFVIII / Pharming Group, Sinopharm (0 Trials) |
|
| rhGH-Emisphere (somatropin oral, oral recombinant human growth hormone) / Novo Nordisk, Ligand (0 Trials) |
|
| RHI629-backup / Reglagene (0 Trials) |
|
| rHIgM12B7 / National Cancer Institute, Mayo Clinic (0 Trials) |
|
| rHIgM22 / Acorda (0 Trials) |
|
| rhIL-15 / National Cancer Institute (1 Trials) |
|
| rhIL-2 / Dongbao Enterprise Group (3 Trials) |
|
| Rhitol (allodepleted T-cell immunotherapeutics) / Sanofi (0 Trials) |
|
| rhMFG-E8 / TheraSource (0 Trials) |
|
| RHO Phyto Transdermal CBG Gel (cannabidiol/cannabigerol) / Avicanna (0 Trials) |
|
| RhoGAM (Rho(D) immune globulin human) / Kedrion (0 Trials) |
|
| RhoNova (GT 038) / Roche (0 Trials) |
|
| Rhopressa (netarsudil) / Alcon (6 Trials) |
|
| rHSA-IFNα2b / Hangzhou Jiuyuan Gene Engineering (0 Trials) |
|
| rHSV-1-APD1 / Yangshengtang (0 Trials) |
|
| RhuDex (AV 1142742) / Dr Falk, Medigene (1 Trials) |
|
| rhuMab IGFR / Roche (0 Trials) |
|
| RHX-317 / Rheos Medicines (0 Trials) |
|
| Riabni (rituximab-arrx) / Amgen, AbbVie (0 Trials) |
|
| Riarify (beclometasone/formoterol/glycopyrrolate) / Chiesi (13 Trials) |
|
| RiaSTAP (fibrinogen concentrate (human)) / CSL Behring (4 Trials) |
|
| ribavirin / Generic mfg. (47 Trials) |
|
| ribavirin / Nagoya University, Tech Manage Corp (0 Trials) |
|
| ribavirin (CCI15106) / GSK (0 Trials) |
|
| ribavirin for inhalation solution / Generic mfg. (0 Trials) |
|
| ribavirin+hydroxychloroquine (BL-8020) / BioLineRx (0 Trials) |
|
| ribaxamase (SYN-004) / Theriva Bio (1 Trials) |
|
| ribitol (BBP-418) / BridgeBio (0 Trials) |
|
| Riboxxim (RGIC100) / Riboxx Pharma (0 Trials) |
|
| Riboxxol (RGIC50) / Riboxx Pharma (0 Trials) |
|
| Riboxxon (RGIC50 bioconjugate) / Riboxx Pharma (0 Trials) |
|
| ribrecabtagene autoleucel (DRL-1801) / Dr. Reddy’s, Galapagos (0 Trials) |
|
| ribuvaptan (BAY 868050) / Bayer (1 Trials) |
|
| ridinilazole (SMT 19969) / Summit Therapeutics, Eurofarma (0 Trials) |
|
| rifabutin intravenous infusion (BV100) / BioVersys (0 Trials) |
|
| Rifalazil (benzoxazinorifamycin) / TrioBiotics Pharma (0 Trials) |
|
| rifampicin / Generic mfg. (118 Trials) |
|
| rifampicin/isoniazid/ethambutol / Generic mfg. (0 Trials) |
|
| rifampicin/isoniazid/ethambutol/pyrazinamide / Generic mfg. (7 Trials) |
|
| rifampicin/isoniazid/pyrazinamide / Generic mfg. (2 Trials) |
|
| RIG-I agonist / Sino Biopharm (0 Trials) |
|
| Rigvir (ECHO-7) / Rigvir Group (0 Trials) |
|
| rilapladib (SB-659032) / GSK (0 Trials) |
|
| rilematovir (JNJ-53718678) / J&J (0 Trials) |
|
| riliprubart (SAR445088) / Sanofi (0 Trials) |
|
| rilotumumab (AMG 102) / Amgen (0 Trials) |
|
| rilpivirine extended release (BRII-778) / Brii Biosci (0 Trials) |
|
| rilpivirine oral suspension (SACT-1) / Aptorum Group (0 Trials) |
|
| Riltrava Aerosphere (formoterol fumarate dihydrate/glycopyrronium/budesonide) / AstraZeneca (0 Trials) |
|
| rilunermin alfa (SCB-313) / Sichuan Clover Biopharma (0 Trials) |
|
| riluzole / Generic mfg. (20 Trials) |
|
| rilvegostomig (AZD2936) / AstraZeneca (0 Trials) |
|
| rilzabrutinib (SAR444671) / Sanofi (8 Trials) |
|
| rimegepant (BHV-3000) / Pfizer (1 Trials) |
|
| rimeporide (EMD 87580) / EspeRare (0 Trials) |
|
| rimiducid (AP1903) / Bellicum (21 Trials) |
|
| Rimmyrah (ranibizumab biosimilar) / Biocad, Qilu Pharma (0 Trials) |
|
|